EUVIMEDEUVIMED entdecken
Crossref

Twenty-Four-Hour Discharge following Transsphenoidal Resection of Pituitary Adenomas: Safety and Feasibility of a Pituitary-Center Cohort

Carlos Perez-Vega, J. Emiliano Sanchez-Garavito, Krishnan Ravindran, Angela M. Donaldson, Osarenoma U. Olomu, Kaisorn L. Chaichana, Alfredo Quinones-Hinojosa, Susan L. Samson, Joao P. Almeida

Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398

DOI: 10.1055/s-0044-1779974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Carlos Perez-Vega und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pituitary surgery integrates a multi-disciplinary approach where Neurosurgeons, Otorhinolaryngologists, and Endocrinologists optimize team dynamics for the benefit of the patient. Surgical intervention carries a recovery period with potential risk for headaches, sinonasal problems, bleeding, cerebrospinal fluid (CSF) leak, as well as diabetes insipidus (DI) and hyponatremia. Even though a hospital setting represents an optimal environment for postoperative follow-up, a selected group of patients might benefit from early hospital discharge. Recent advances in preoperative planning, endoscopic surgery, and multi-disciplinary collaboration have allowed improved outcomes in pituitary surgery. The objective of this study is to analyze the safety and feasibility of 24-hour discharge following transsphenoidal surgery in a prospective cohort of patients, and identify clinical criteria for protocolization.

Methods

All consecutive patients with pituitary adenomas (functional and nonfunctional) and cystic lesions operated on by three skull-base neurosurgeons via endoscopic transsphenoidal approach were included in the study from October 2020 to December 2022. The present admission protocol was implemented to optimize early patient discharge and it is described as follows: preoperative evaluations by Neurosurgery and Endocrinology are performed in the week preceding intervention; pituitary endocrinologist communicates plan to all team members regarding pre- and postoperative steroid dose, hormone replacement, sodium/urine watch, and POD1 laboratories personalized to the patient’s needs. Patient is assessed for discharge by the multidisciplinary team following postoperative MRI within 24 hours. Two study groups were identified based on length of stay following intervention (24-hour discharge or beyond). Patient demographic, clinical, laboratorial, radiographic, surgical, and postoperative variables were collected for each of the subjects.

Results

One hundred and seventy patients underwent transsphenoidal surgery during the duration of the study, 120 (70.5%) were discharged within 24-hours while 50 (29.5%) were discharged at a later time. Mean age was 53.78 (±16.39) and 53.36 (18.32), respectively, and female proportion was 54.16% and 52%. Variables that were predictive of a longer hospital stay included postoperative CSF leak ( p = 0.0024), lumbar drain placement ( p = 0.0001), admission to NeuroICU following surgery ( p 0.05).

Conclusion

Twenty-four-hour discharge following pituitary surgery is safe and feasible in selected patients, specifically those without CSF leak, lumbar drain or requiring intensive level of care. Safety for early discharge appears to be independent of age, sex, preoperative hormone deficiencies, tumor functional status or diameter. The identification and further validation of these variables would allow early discharge protocolization and potential healthcare cost-saving effects. Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Perez-Vega, C., Sanchez-Garavito, J. E., Ravindran, K., Donaldson, A. M., Olomu, O. U., Chaichana, K. L., Quinones-Hinojosa, A., Samson, S. L., & Almeida, J. P. (2024). Twenty-Four-Hour Discharge following Transsphenoidal Resection of Pituitary Adenomas: Safety and Feasibility of a Pituitary-Center Cohort. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1779974

Vancouver

Perez-Vega C, Sanchez-Garavito JE, Ravindran K, Donaldson AM, Olomu OU, Chaichana KL, et al. Twenty-Four-Hour Discharge following Transsphenoidal Resection of Pituitary Adenomas: Safety and Feasibility of a Pituitary-Center Cohort. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1779974

BibTeX
@article{PerezVega2024,
  author = {Perez-Vega, Carlos and Sanchez-Garavito, J. Emiliano and Ravindran, Krishnan and Donaldson, Angela M. and Olomu, Osarenoma U. and Chaichana, Kaisorn L. and Quinones-Hinojosa, Alfredo and Samson, Susan L. and Almeida, Joao P.},
  title = {Twenty-Four-Hour Discharge following Transsphenoidal Resection of Pituitary Adenomas: Safety and Feasibility of a Pituitary-Center Cohort},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2024},
  volume = {85},
  number = {S 01 S 01},
  pages = {S1--S398},
  doi = {10.1055/s-0044-1779974}
}
Kostenlos starten →